The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience
Released on J-STAGE: May 30, 2025 |
Article ID 25010
Noriyoshi Iriyama, Katsuhiro Miura, Hiromichi Takahashi, Masaru Nakagawa, Kazuhide Iizuka, Shimon Otake, Takashi Hamada, Takashi Koike, Kazuya Kurihara, Toshihide Endo, Hideki Nakamura